VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $183,000 | -99.4% | 1,800 | -98.9% | 0.16% | -99.3% |
| Q3 2015 | $28,444,000 | -11.4% | 159,461 | +10.4% | 24.08% | +33.5% |
| Q2 2015 | $32,092,000 | +9.9% | 144,461 | -1.7% | 18.04% | +5.5% |
| Q1 2015 | $29,197,000 | -0.2% | 147,000 | -28.1% | 17.11% | +0.5% |
| Q4 2014 | $29,266,000 | +12.9% | 204,500 | +3.5% | 17.03% | +12.7% |
| Q3 2014 | $25,912,000 | +4.0% | 197,500 | 0.0% | 15.11% | +11.2% |
| Q2 2014 | $24,909,000 | +4.7% | 197,500 | +9.4% | 13.60% | -7.5% |
| Q1 2014 | $23,795,000 | +12.3% | 180,500 | 0.0% | 14.69% | -2.8% |
| Q4 2013 | $21,191,000 | +17.7% | 180,500 | +4.6% | 15.12% | +9.7% |
| Q3 2013 | $17,997,000 | +32.8% | 172,500 | +9.5% | 13.78% | +34.9% |
| Q2 2013 | $13,557,000 | – | 157,500 | – | 10.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |